Cite
HARVARD Citation
Eyal, N. et al. (2022). COVID vaccine efficacy against the B.1.351 ("South African") variant—The urgent need to lay the groundwork for possible future challenge studies. Human vaccines & immunotherapeutics. 18 (1), p. . [Online].